Skip to content
Screener

Opko Health OPK Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$151.7MBeat by $11.9M
EPS$0.03Beat by $0.05
Revenue estimate$139.8M
EPS estimate-$0.02

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$136.6M
EPS estimate-$0.07

Financials

Q3 2025

Income statement

See full
Revenue$151.7M-12.6%
Gross profit$49.9M+24.3%
Operating income$48.1M+172%
Net income$21.6M-13.1%
EPS (diluted)$0.030.0%

Balance sheet

See full
Total debt$52.7M-27.7%
Total equity$1.3B-7.0%
Total assets$2.0B-11.6%

Cash flow

See full
Operating cash flow-$34.6M+55.1%
CapEx$3.1M-60.5%
Free cash flow-$37.8M+55.6%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.23B+18.4%
Enterprise value$1.28B+15.4%
P/S1.9×+0.5×

Profitability

See full
Gross margin35.3%+5.3pp
Operating margin-17.5%—
Net margin-28.1%+27.5pp
FCF margin-33%+7.0pp

Returns & leverage

See full
Return on equity-13.3%+9.6pp
Debt / equity0×0.0×
Current ratio3.7×+0.7×

Segments

By product

See full
Transfer Of Intellectual Property And Other$18.7M+41.8%

FAQ

When did Opko Health report Q3 2025 earnings?
Opko Health (OPK) reported Q3 2025 earnings on October 29, 2025 after market close.
What were Opko Health's Q3 2025 revenue and EPS?
Opko Health reported revenue of $151.7M and eps of $0.03 for Q3 2025.
Did Opko Health beat estimates in Q3 2025?
Revenue beat the consensus estimate of $139.8M by $11.9M. EPS beat the consensus estimate of $-0.02 by $0.05.
How did Opko Health's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 12.6% from $173.6M a year earlier and eps grew 0.0% from $0.03.
Where can I find Opko Health's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-256325) and the 10-Q periodic report (0001193125-25-256328) directly on SEC EDGAR. The filing index links above go to sec.gov.